Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

IMPact on Revascularization Outcomes of intraVascular Ultrasound Guided Treatment of Complex Lesions and Economic Impact (IMPROVE)

NCT04221815 is registered in ClinicalTrials.gov with Medstar Health Research Institute as lead sponsor.

NCT NCT04221815
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04221815 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
IMPact on Revascularization Outcomes of intraVascular Ultrasound Guided Treatment of Complex Lesions and Economic Impact (IMPROVE)
Lead sponsor
Medstar Health Research Institute
Phase
Not applicable
Overall status
Active, not recruiting
Start date
October 14, 2020
Completion date
September 30, 2027
Enrollment
3,100 (estimated)
Sites
61

Conditions

As the registry lists them; a condition with its own page is linked.

atherosclerosis